Latest News for: certolizumab pegol

Edit

Lupin, Zentiva Group ink agreement to commercialise biosimilar Certolizumab Pegol

Business Line 10 Jul 2025
Both parties will invest in the development of the new biosimilar ....
Edit

Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global markets

The Times of India 09 Jul 2025
... its biosimilar 'Certolizumab Pegol' across global markets.
Edit

Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol) (Form 6-K) (Alvotech SA)

Public Technologies 01 Jul 2025
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol) ... Certolizumab pegol is a TNF-alpha inhibitor indicated for a variety of inflammatory diseases.
  • 1

Article Search

tools
×
×
×
×